Our aim is to develop within the EU region an original research activity programme with technical applications to the design of new solid state pharmaceuticals, with a view to facilitating the development of both new and existing drugs in forms with improved bioavailability, efficacy, chemical and physical stability, safety and predictability. The new forms will mainly be based on nanoparticle technologies, amorphous drug forms and molecular complexations. The participation of a pharmaceutical company (SME Ghent) in the project will provide fast and efficient validation of the most innovative developments. We will create in the region a training centre for a new trade dedicated to the optimization of the solid-state drug manufacturing processes. This training will be provided jointly by the members of the partnership. This type of trade will meet the need of pharmaceutical firms in order to overcome the major bottlenecks of the drug development.